|

VA Watchdog Stuff
cups, hats, shirts
click here to
support the site

Be sure to get all five
VA Watchdog dot Org
RSS feeds --
Daily VA
News Flashes
House CVA
Veterans' News
Senate CVA
Veterans' News
VA Press
Releases
VSO Press
Releases

Download
your
free copy of the
2007 VA benefits
handbook here...

|
Printer-Friendly Version
RESEARCH: AGENT ORANGE CHEMICAL, DIOXIN, ATTACKS
CELLULAR MACHINERY -- Researchers have
demonstrated
the process by which the cancer-causing chemical
dioxin
attacks the cellular machinery, disrupts normal
cellular
function and ultimately promotes tumor
progression.

For more about veterans and Agent Orange, use the
VA Watchdog search engine...click here...
http://www.yourvabenefits.org/sessearch.php?q=agent+orange&op=ph
Story here...
http://www.eurekalert.org/pub_releases/2007-12/uop-aoc121307.php
Story below:
-------------------------
Contact: Jordan Reese
jreese@upenn.edu
215-573-6604
University of Pennsylvania
Agent orange chemical, dioxin, attacks the
mitochondria to cause cancer, says Penn research team
PHILADELPHIA -- Researchers with the University of Pennsylvania School of
Veterinary Medicine have demonstrated the process by which the
cancer-causing chemical dioxin attacks the cellular machinery, disrupts
normal cellular function and ultimately promotes tumor progression.
The team identified for the first time that mitochondria, the cellular
sub-units that convert oxygen and nutrients into cellular fuel, are the
target of tetrachlorodibenzodioxin, or TCDD. The study showed that TCDD
induces mitochondria-to-nucleus stress signaling, which in turn induces
the expression of cell nucleus genes associated with tumor promotion and
metastasis.
Article continues below:
"ASK
THE BUILDER" VIDEOS -- HOME IMPROVEMENT TIPS
(use left/right arrows in screen to view more videos)
|
The mechanism the research team has described is
directly relevant to understanding incidences of breast and other cancers
in human populations exposed to these chemicals. With a better
understanding of this underlying cellular mechanism, researchers hope to
improve their understanding of tumor growth and promotion.
"Now that we have identified this signaling mechanism we can look at ways
to disrupt this complex chain of events," said Narayah Avadhani, chair of
the Department of Animal Biology at Penn's School of Veterinary Medicine
and the study's lead investigator. "Our ultimate goal is to block the
propagation of this mitochondrial stress signaling and inhibit the
expression of the proteins that combine to assist cancer growth."
A well-characterized mechanism of TCDD action occurs through activation of
arylhydrocarbon receptors, AhR, by directly binding to the protein
subunits. Activated AhR mediates the transcriptional activation of many
genes including those involved in fatty acid metabolism, cell cycle
regulation and immune response. The present study, however, shows that
TCDD starts the chain of events that promote tumor progression in vivo by
directly targeting mitochondrial transcription and induction of
mitochondrial stress signaling. A unique feature of this TCDD-induced
signaling is that it does not involve the action of AhR but occurs through
increased calcium levels in cells and activation of calcium responsive
factors. A net result of signaling cascade is slowing down of cellular
apoptosis, increased cell proliferation and tumor cell metastasis. Taken
together, this study describes a novel mechanism of TCDD-induced tumor
progression and emergence of metastatic cancer cells.
TCDD is the most toxic compound in the dioxin family. Formed as a
by-product during waste incineration, paper, chemical and pesticide
manufacturing, it was the toxic ingredient in Agent Orange and closed the
Love Canal in Niagara Falls. The public health impact of dioxin, according
to the Environmental Protection Agency, compares to that of the pesticide
DDT.
###
The study appears online and in the Dec. 17 issue of the Proceedings of
the National Academy of Sciences and was performed by Avadhani, Gopa
Biswas, Satish Srinivasan and Hindupur Anandatheerthavarada of the Penn
School of Veterinary Medicine.
The research was supported by a grant from the National Cancer Institute
and the National Institutes of Health.
-------------------------
Larry Scott --
Don't forget to read all of today's VA
News Flashes (click here)
Click here to make VA Watchdog dot Org your homepage
email Larry
(go
back to VA Watchdog dot Org Home Page) |

VA Watchdog Stuff
cups, hats, shirts
click here to
support the site

|